In this study, we checked lactobacilli strains of human origin for their potential as probiotic. Samples were collected from oral mucosa of 16 healthy individuals, out of which twenty isolates were obtained and two of them were selected and identified as Lactobacillus plantarum (G1) and L. casei (G3). Both isolates exhibited antagonistic action towards pathogenic microorganisms such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Salmonella abony, and Clostridium sporogenes, but not on the growth of Candida albicans. The bacteriocin activity against Staphylococcus aureus ATCC 6358-P was shown only by L. plantarum G1. Moreover, the isolates G1 and G3 showed good viability in the acid gastric environment and in the gut environment containing bovine bile salts. The viability of G1 and G3 isolates in the gastrointestinal tract, and the adhesion to the intestinal mucosa were also confirmed in vivo. The biochemical tests of blood samples revealed lower levels of serum triglycerides and cholesterol, as well as reduced activity of alkaline phosphatase in all lactobacilli-treated Wistar rats, compared to control ones. No toxicity for NMRI Ham mice was observed. According to our experimental results, these findings imply that L. plantarum G1 and L. casei G3 could be characterized as potential probiotics.
Probiotic features of two oral Lactobacillus
In particular, Lactobacillus species found in the gastrointestinal tract have received tremendous attention due to their health-promoting properties (39) . Their useful action on the intestinal microbiota results in the protection of the human body from pathogens through different mechanisms, including competitive binding to the intestinal mucosa and production of antimicrobial substances, such as organic acid, primary lactic acid, carbon dioxide, and bacteriocin (3, 4) . In addition, they are used for the prevention and treatment of gastrointestinal disorders, overcoming intolerance to lactose, the host immune responses modulation, and prevention of cancer (22) . Also, they showed a protective action against cardiovascular diseases through the reduction of serum cholesterol and triglyceride levels, the removal of cholesterol by the cholesterol micelles and precipitation of the cholesterol with bile acids (1, 40) .
In view of all these facts, the purpose of this study was to isolate and characterize the lactobacilli originating from the human oral mucosa, as well as to evaluate their probiotic and some functional properties like their effects on serum lipids content and the alkaline phosphatase (ALP) activity. The main contribution of these investigations is discovering new potential probiotic strains that could eventually be usefully applied in practice.
MATERIALS AND METHODS

Bacterial isolation methods
MRS medium (DeMan-Rogosa-Sharpe; Merck GmbH, Darmstadt, Germany) was used for isolation, multiplication, and recovery of lactobacilli. The oral mucosa material was obtained from 16 healthy subjects between 10 and 50 years of age. Each swab was suspended in 10 ml of phosphate buffer with 0.05% cystein and homogenised for 2 min. A set of 10-fold dilutions was made in the sterile phosphate buffer, pH 7.2.
Subsequently, 100 µl of each dilution was smeared on the surface of MRS agar (Merck). The inoculated plates were incubated at 37 o C in the anaerobic environment (Gas pack vessel, BioMerieux, France) for 72 h. Individual colonies were stickled on fresh MRS plates and used as the starting material for bacterial assessment.
Strains, media, and growth conditions
Staphylococcus aureus ATCC 6538-P, Escherichia coli 
Identification of lactobacilli isolates
All isolates were preliminary identified as lactobacilli, using the following physiological tests: the growth at different temperatures (15°C, 30°C, 37°C and 45°C) in MRS broth for 5 days; the growth in MRS broth with 2%, 4% and 6.5% (w/v) NaCl for 5 days; CO 2 production from glucose in MRS broth lacking beef extract and containing inverted Durham's tubes;
L-arginine and esculin hydrolysis, and growth in 10% skimmed milk medium (38 determination, a multiplex PCR assay with the recA gene based specific primers plantF, paraF, pentF, and pREV was performed as previously described (37) .
Agar-well diffusion assay
The overnight cultures of the indicator strains were mixed at 1% (10 6 CFU/ml) with melted nutrient agar poured in sterile 
Bacteriocin assay
The overnight cultures of the G1 and G3 strains were 
growth in mixed cultures
To test the effect of single or mixed cultures of L.
plantarum G1 and L. casei G3 on the growth of pathogenic strains, the TSB medium was initially inoculated with lactobacilli (10 7 CFU/ml) or single inoculations and 10 7 CFU/ml or 10 10 CFU/ml when mixed cultures of G1 and G3
were used. The ratio of mixed lactobacilli G1 and G3 was 1:1.
Subsequently, S. aureus ATCC 6538-P (10 5 CFU/ml), E. coli 
In vitro testing -resistance to artificial gastric and intestinal fluids
The test of bacterial survival in artificial gastric juice (AGJ) was performed as follows: 10 ml of MRS medium was inoculated at 1% (v/v) with lactobacilli strains and incubated at 
Experimental procedure
The abnormal toxicity test was used to assess the effects of the G1 and G3 isolates applied in a single daily oral dose of 
Statistical data analyses
The effect of single L. plantarum G1 or L. casei G3 on S.
aureus ATCC 6538-P, E. coli ATCC 8739, and S. abony NTCC 6017 growth was observed to be dependent of the pathogen (Table 2) . When G1 was mixed with these pathogens, the growth of the pathogen was 6.5 log units lower for S.
aureus, 2.1 log units lower for E. coli and 0.8 log units for S.
abony, when compared to the growth of the pure culture of the pathogen. On the other hand, the effect of the pathogen growth Probiotic features of two oral Lactobacillus reduction was in the range of 1-2 log units when G3 was used.
The cumulative effect of G1 and G3 (10 7 CFU/ml) resulted in the reduction of S. aureus growth for 7.5 log units, of E. coli for 7.2 log units, and of S. abony for 5.7 log units, when compared to control cultures. The results for mixed cultures of G1 and G3 (10 10 CFU/ml) showed that the complete inhibition of pathogenic bacteria growth was observed after 24 h incubation. AGJ, a decreased count of viable G1 by 1.94 log CFU/ml, and G3 by 1.74 log CFU/ml was observed (Fig. 1A) . In addition, after 120-min exposure to the bovine bile salts solution, viable G1 and G3 decreased, respectively, 0.45 log CFU/ml, and 0.22 log CFU/ml (Fig. 1B) . (Table 3) . The resistance to specific conditions in stomach and duodenum is another important factor that could explain the efficiency of some probiotic preparations. When compared to the literature data, both strains used in our study showed a high degree of viability in the simulated conditions of the proximal and the distal part of the gastrointestinal tract (24, 34) . Gastric digestion at pH 2 did not significantly affect the survival of G1
and G3 and even after 120 min the amount of viable bacteria decreased by less than 2 log units. In similar experiment, Pereira and Gibson (32) showed that the strain L. casei Shirota exhibited a significant decrease of 3-4 log units after 60 min of exposure to gastric digestion. The proposed bile concentration to which a probiotic strain should be tolerant varies from 0.15 to 0.6% (14) . Lactobacilli tested in this study survived in the presence of 0.5% bile salts and appear to be resistant to the intestinal conditions. Overall, obtained results indicate that the viability of G1 and G3 strains in simulated GIT conditions was sufficient for their successful and massive passage through this system.
To assess the safety of G1 and G3 strains, NMRI Ham mice were fed with bacteria in a dose 100 times greater than the average most frequently administered probiotic dose for the oral use. No feeding or behavioural changes were observed in the treated mice, when compared to the control group. None of the treated mice died during 72 h following lactobacilli administration. Therefore, G1 and G3 most probably did not induce toxic effects, i.e. they were considered safe after the oral administration. In vivo studies on Wistar rats showed good viability of lactobacilli in the GIT. Namely, G1 and G3 strains were re-identified in faecal samples of the treated Wistar rats.
Moreover, a lower E. coli count in faecal samples was seen in
Wistar rats treated with G1. In addition, G1 and G3 strains were also re-identified in the material taken from the surface of ileum mucosa of Wistar rats. These results could be an indicator of good colonization ability and bacterial adhesiveness of G1 and G3 to the intestinal mucosa as described previously (28) .
The analysis of biochemical parameters of blood samples 
